MeSH term
Frequency | Condition_Probility | English Abstract | 7 | 0.0 |
Humans | 43 | 0.0 |
Time Factors | 4 | 0.0 |
Aged | 7 | 0.0 |
Animals | 9 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Mice | 6 | 0.0 |
Protein Binding | 3 | 0.0 |
Receptors, CXCR4/drug effects/*physiology | 2 | 33.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
*Adaptor Proteins, Signal Transducing | 4 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Cell Line | 2 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Mutation | 2 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Transfection | 2 | 0.0 |
Equipment Design | 2 | 1.0 |
Bone Marrow/*pathology | 4 | 2.0 |
Cell Adhesion | 6 | 0.0 |
Fibroblasts/pathology | 4 | 5.0 |
Integrins/physiology | 2 | 2.0 |
Stromal Cells/pathology | 2 | 3.0 |
Comparative Study | 10 | 0.0 |
International Cooperation | 2 | 2.0 |
Reproducibility of Results | 2 | 0.0 |
Adult | 12 | 0.0 |
Male | 16 | 0.0 |
Acute Disease | 3 | 0.0 |
Bone Marrow Cells | 3 | 0.0 |
Cell Adhesion Molecules/physiology | 2 | 2.0 |
Cells, Cultured | 12 | 0.0 |
Leukemia, Myeloid/*pathology | 2 | 3.0 |
*Bone Marrow Cells | 7 | 2.0 |
Fibroblasts/*metabolism | 2 | 1.0 |
Base Sequence | 3 | 0.0 |
Bone Marrow/*metabolism | 2 | 4.0 |
Immunohistochemistry | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Stromal Cells/metabolism | 2 | 2.0 |
Rats | 3 | 0.0 |
Adolescent | 8 | 0.0 |
Cell Separation | 2 | 0.0 |
Child, Preschool | 6 | 0.0 |
*Apoptosis | 2 | 0.0 |
Colony-Forming Units Assay | 3 | 0.0 |
Female | 11 | 0.0 |
Fibroblasts/cytology | 4 | 1.0 |
Infant | 3 | 0.0 |
Middle Aged | 7 | 0.0 |
Cell Division/drug effects | 4 | 0.0 |
Fibroblasts/physiology | 2 | 1.0 |
Leukemia/*pathology | 2 | 4.0 |
Bone Marrow Transplantation/*pathology | 2 | 16.0 |
Child | 6 | 0.0 |
Genotype | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use | 2 | 0.0 |
Remission Induction | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Granulocytes/*cytology | 2 | 8.0 |
Kinetics | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
